Postmenopausal Osteoporosis
Postmenopausal osteoporosis is a condition where bones become weaker after menopause, when bone loss speeds up. It can make a person more likely to have fractures.
Key points
- Slow onset: It can develop over years without clear symptoms, so a fracture may reveal it.
- Fracture locations: Osteoporosis-related fractures often involve the wrist, hip or spine.
- Fragile bones: A fall or sudden impact can lead to a fracture when bones have become fragile.
Medicines listed for Postmenopausal Osteoporosis
The six products listed for postmenopausal osteoporosis contain Estradiol, Tibolone, calcitonin salmon, raloxifene, risedronate or conjugated oestrogens. The range includes tablets and a spray. These ingredients represent hormone-related medicines, calcitonin, a selective oestrogen receptor modulator and a bisphosphonate, classes used in the broader management of osteoporosis and bone health.





